intrafollicular t-cells an early independent predictor of failure in fl
Published 4 years ago • 32 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
8:57
outcomes of sct in t-all and t-lbl
-
1:47
individualized machine learning predictions of allosct outcomes in aml: the harmony platform
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
9:04
how are et, pv and myelofibrosis monitored?
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:17
the efficacy of olutasidenib in aml following venetoclax failure
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
2:29
inherited hematopoietic failure & pre-leukemic syndromes: accurate diagnosis
-
2:41
an overview of the latest advances in hematology
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml